Retinoids regulate human amniotic tissue-type plasminogen activator gene by a two-step mechanism

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 6 B, 2010, Pages 1793-1805

  Borel, Valerie ^a   Marceau, Geoffroy ^a   Gallot, Denis ^a,b   Blanchon, Loïc ^a   Sapin, Vincent ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

Amnion; Foetal membranes; Human; Retinoic acid receptor beta; Retinoids; Tissue type plasminogen activator

Indexed keywords

4 (7,8,9,10 TETRAHYDRO 5,7,7,10,10 PENTAMETHYL 5H BENZO[E]NAPHTHO[2,3 B][1,4]DIAZEPIN 13 YL)BENZOIC ACID; DIBENZAZEPINE DERIVATIVE; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR BETA; RETINOID; RETINOID X RECEPTOR; SMALL INTERFERING RNA; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTION FACTOR SP1;

AMNION; ARTICLE; CELL LINE; DNA RESPONSIVE ELEMENT; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PROTEIN BINDING; TRANSCRIPTION INITIATION;

AMNION; CELL LINE; DIBENZAZEPINES; GENE EXPRESSION REGULATION; HUMANS; PROTEIN BINDING; RECEPTORS, RETINOIC ACID; RESPONSE ELEMENTS; RETINOID X RECEPTORS; RETINOIDS; RNA, SMALL INTERFERING; SP1 TRANSCRIPTION FACTOR; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTIONAL ACTIVATION;

EID: 77955138270     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00802.x     Document Type: Article

References (43)

1. Niknejad H, Peirovi H, Jorjani M. Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater. 2008, 15:88-99.
2. Bernirschke K, Kaufman P. Pathology of the human placenta 1995, 4th edition, New York, Springer-Verlag
3. Malak TM, Ockleford CD, Bell SC. Confocal immunofluorescence localization of collagen types I, III, IV, V and VI and their ultrastructural organization in term human fetal membranes. Placenta. 1993, 14:385-406.
4. Bryant-Greenwood GD. The extracellular matrix of the human fetal membranes: structure and function. Placenta. 1998, 19:1-11.
5. Hulboy DL, Rudolph LA, Matrisian LM. Matrix metalloproteinases as mediators of reproductive function. Mol Hum Reprod. 1997, 3:27-45.
6. Parry S, Strauss JF. Premature rupture of the fetal membranes. N Engl J Med. 1998, 338:663-70.
7. DeClerck YA, Laug WE. Cooperation between matrix metalloproteinases and the plasminogen activator-plasmin system in tumor progression. Enzyme Protein. 1996, 49:72-84.
8. Lijnen HR, Silence J, Lemmens G. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system. Thromb Haemost. 1998, 79:1171-6.
9. Bryant-Greenwood GD, Schwabe C. Human relaxins: chemistry and biology. Endocr Rev. 1994, 15:5-26.
10. Bogic LV, Ohira RH, Yamamoto SY. Tissue plasminogen activator and its receptor in the human amnion, chorion, and decidua at preterm and term. Biol Reprod. 1999, 60:1006-12.
11. Kooistra T, Lansink M, Arts J. Involvement of retinoic acid receptor alpha in the stimulation of tissue-type plasminogen-activator gene expression in human endothelial cells. Eur J Biochem. 1995, 232:425-32.
12. Montemurro P, Barbuti G, Conese M. Retinoic acid stimulates plasminogen activator inhibitor 2 production by blood mononuclear cells and inhibits urokinase-induced extracellular proteolysis. Br J Haematol. 1999, 107:294-9.
13. Hultman K, Tjarnlund-Wolf A, Fish RJ. Retinoids and activation of PKC induce tissue-type plasminogen activator expression and storage in human astrocytes. J Thromb Haemost. 2008, 6:1796-803.
14. Rickles RJ, Darrow AL, Strickland S. Differentiation-responsive elements in the 5' region of the mouse tissue plasminogen activator gene confer two-stage regulation by retinoic acid and cyclic AMP in teratocarcinoma cells. Mol Cell Biol. 1989, 9:1691-704.
15. Merchiers P, Bulens F, De Vriese A. Involvement of Sp1 in basal and retinoic acid induced transcription of the human tissue-type plasminogen activator gene. FEBS Lett. 1999, 456:149-54.
16. Niederreither K, Dolle P. Retinoic acid in development: towards an integrated view. Nat Rev Genet. 2008, 9:541-53.
17. Germain P, Chambon P, Eichele G. International Union of Pharmacology. LX. Retinoic acid receptors. Pharmacol Rev. 2006, 58:712-25.
18. Marceau G, Gallot D, Lemery D. Metabolism of retinol during mammalian placental and embryonic development. Vitam Horm. 2007, 75:97-115.
19. Marceau G, Gallot D, Borel V. Molecular and metabolic retinoid pathways in human amniotic membranes. Biochem Biophys Res Commun. 2006, 346:1207-16.
20. Li Y, Hashimoto Y, Agadir A. Identification of a novel class of retinoic acid receptor beta-selective retinoid antagonists and their inhibitory effects on AP-1 activity and retinoic acid-induced apoptosis in human breast cancer cells. J Biol Chem. 1999, 274:15360-6.
21. Han YM, Romero R, Kim JS. Region-specific gene expression profiling: novel evidence for biological heterogeneity of the human amnion. Biol Reprod. 2008, 79:954-61.
22. Bulens F, Ibanez-Tallon I, Van Acker P. Retinoic acid induction of human tissue-type plasminogen activator gene expression via a direct repeat element (DR5) located at -7 kilobases. J Biol Chem. 1995, 270:7167-75.
23. Brand N, Petkovich M, Krust A. Identification of a second human retinoic acid receptor. Nature. 1988, 332:850-3.
24. Elder JT, Astrom A, Pettersson U. Differential regulation of retinoic acid receptors and binding proteins in human skin. J Invest Dermatol. 1992, 98:673-9.
25. Mader S, Chen JY, Chen Z. The patterns of binding of RAR, RXR and TR homo- and heterodimers to direct repeats are dictated by the binding specificites of the DNA binding domains. EMBO J. 1993, 12:5029-41.
26. Nelson JD, Denisenko O, Bomsztyk K. Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat Protoc. 2006, 1:179-85.
27. Ross SA, McCaffery PJ, Drager UC. Retinoids in embryonal development. Physiol Rev. 2000, 80:1021-54.
28. Lania L, Majello B, De Luca P. Transcriptional regulation by the Sp family proteins. Int J Biochem Cell Biol. 1997, 29:1313-23.
29. Husmann M, Dragneva Y, Romahn E. Nuclear receptors modulate the interaction of Sp1 and GC-rich DNA via ternary complex formation. Biochem J. 2000, 352:763-72.
30. de The H, Vivanco-Ruiz MM, Tiollais P. Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature. 1990, 343:177-80.
31. Jenkins DM, O'Neill M, Mattar M. Degenerative changes and detection of plasminogen in fetal membranes that rupture prematurely. Br J Obstet Gynaecol. 1983, 90:841-6.
32. Rochette-Egly C, Gaub MP, Lutz Y. Retinoic acid receptor-beta: immunodetection and phosphorylation on tyrosine residues. Mol Endocrinol. 1992, 6:2197-209.
33. Thompson EA, Nelles L, Collen D. Effect of retinoic acid on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cells. Eur J Biochem. 1991, 201:627-32.
34. Lachili B, Faure H, Smail A. Plasma vitamin A, E, and beta-carotene levels in adult post-partum Algerian women. Int J Vitam Nutr Res. 1999, 69:239-42.
35. Sapin V, Alexandre MC, Chaib S. Effect of vitamin A status at the end of term pregnancy on the saturation of retinol binding protein with retinol. Am J Clin Nutr. 2000, 71:537-43.
36. Scaife AR, McNeill G, Campbell DM. Maternal intake of antioxidant vitamins in pregnancy in relation to maternal and fetal plasma levels at delivery. Br J Nutr. 2006, 95:771-8.
37. Suzuki Y, Shimada J, Shudo K. Physical interaction between retinoic acid receptor and Sp1: mechanism for induction of urokinase by retinoic acid. Blood. 1999, 93:4264-76.
38. Lu S, Saydak M, Gentile V. Isolation and characterization of the human tissue transglutaminase gene promoter. J Biol Chem. 1995, 270:9748-56.
39. Kim Y, Ratziu V, Choi SG. Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. J Biol Chem. 1998, 273:33750-8.
40. Panariello L, Quadro L, Trematerra S. Identification of a novel retinoic acid response element in the promoter region of the retinol-binding protein gene. J Biol Chem. 1996, 271:25524-32.
41. Wolf AT, Medcalf RL, Jern C. The t-PA -7351C>T enhancer polymorphism decreases Sp1 and Sp3 protein binding affinity and transcriptional responsiveness to retinoic acid. Blood. 2005, 105:1060-7.
42. Dalmolin RJ, Zanotto-Filho A, De Oliveira RB. Retinol and retinoic acid increase MMP-2 activity by different pathways in cultured Sertoli cells. Free Radic Res. 2007, 41:1338-47.
43. Zaragoza R, Gimeno A, Miralles VJ. Retinoids induce MMP-9 expression through RARalpha during mammary gland remodeling. Am J Physiol Endocrinol Metab. 2007, 292:E1140-8.